Labotest-bb lt00007814

CAS No. 103582-41-8

Labotest-bb lt00007814( —— )

Catalog No. M37573 CAS No. 103582-41-8

Labotest-bb lt00007814 ((1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime) is a compound that can be used in biological research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 188 In Stock
10MG 290 In Stock
25MG 487 In Stock
50MG 694 In Stock
100MG 977 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Labotest-bb lt00007814
  • Note
    Research use only, not for human use.
  • Brief Description
    Labotest-bb lt00007814 ((1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime) is a compound that can be used in biological research.
  • Description
    Labotest-bb lt00007814 ((1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime) is a compound that can be used in biological research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103582-41-8
  • Formula Weight
    305.45
  • Molecular Formula
    C19H31NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(\CCCCCCCCCCC)(=N\O)/C1=C(O)C=CC(C)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DFO

    DFO (9H-1,8-Diazafluoren-9-one) is used to find fingerprints on porous surfaces.1,8-diazafluoren-9-one (DFO) is used in the forensic field to enhance latent fingerprints deposited on porous surfaces due to the formation of fluorescent products by reacting with the amino acids present in the papillary exudate. DFO has been the most used because of its excellent enhancing properties.

  • Fenchlonine

    4-Chloro-DL-phenylalanine is a pharmaceutical intermediate.

  • Cenobamate

    Cenobamate (YKP-3089, YKP3089) is a potential anti-seizure agent with currently unknown mechanisms of action.